| Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the … J Cuzick, M Dowsett, S Pineda, C Wale, J Salter, E Quinn, L Zabaglo, ... J Clin Oncol 29 (32), 4273-4278, 2011 | 866 | 2011 |
| Challenges in the integration of omics and non-omics data E López de Maturana, L Alonso, P Alarcón, IA Martín-Antoniano, S Pineda, ... Genes 10 (3), 238, 2019 | 114 | 2019 |
| Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen … K Lundgren, M Brown, S Pineda, J Cuzick, J Salter, L Zabaglo, A Howell, ... Breast Cancer Research 14, 1-11, 2012 | 111 | 2012 |
| Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer S Pineda, FX Real, M Kogevinas, A Carrato, SJ Chanock, N Malats, ... PLoS genetics 11 (12), e1005689, 2015 | 75 | 2015 |
| Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease A Taubes, P Nova, KA Zalocusky, I Kosti, M Bicak, MY Zilberter, Y Hao, ... Nature Aging 1 (10), 932-947, 2021 | 70 | 2021 |
| Abstract S1-7: Lack of Correlation between Gene Variants in Tamoxifen Metabolizing Enymes with Primary Endpoints in the ATAC Trial. JM Rae, S Drury, DF Hayes, V Stearns, JN Thibert, BP Haynes, J Salter, ... Cancer Research 70 (24_Supplement), S1-7-S1-7, 2010 | 65 | 2010 |
| Novel non-histocompatibility antigen mismatched variants improve the ability to predict antibody-mediated rejection risk in kidney transplant S Pineda, TK Sigdel, J Chen, AM Jackson, M Sirota, MM Sarwal Frontiers in immunology 8, 1687, 2017 | 52 | 2017 |
| Characterizing pre-transplant and post-transplant kidney rejection risk by B cell immune repertoire sequencing S Pineda, TK Sigdel, JM Liberto, F Vincenti, M Sirota, MM Sarwal Nature communications 10 (1), 1906, 2019 | 40 | 2019 |
| Predictive algorithms for adjuvant therapy: TransATAC M Dowsett, J Salter, L Zabaglo, E Mallon, A Howell, AU Buzdar, J Forbes, ... Steroids 76 (8), 777-780, 2011 | 37 | 2011 |
| Immunohistochemistry-based taxonomical classification of bladder cancer predicts response to neoadjuvant chemotherapy A Font, M Domènech, R Benítez, M Rava, M Marqués, JL Ramírez, ... Cancers 12 (7), 1784, 2020 | 34 | 2020 |
| Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis S Pineda, RL Milne, ML Calle, N Rothman, E López de Maturana, ... PLoS One 9 (5), e89952, 2014 | 33 | 2014 |
| Toward the integration of Omics data in epidemiological studies: still a “long and winding road” E Lopez de Maturana, S Pineda, A Brand, K Van Steen, N Malats Genetic epidemiology 40 (7), 558-569, 2016 | 29 | 2016 |
| FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium D Agarwal, S Pineda, K Michailidou, J Herranz, G Pita, LT Moreno, ... British journal of cancer 110 (4), 1088-1100, 2014 | 29 | 2014 |
| Framework for the integration of genomics, epigenomics and transcriptomics in complex diseases S Pineda, P Gomez-Rubio, A Picornell, K Bessonov, M Márquez, ... Human Heredity 79 (3-4), 124-136, 2015 | 25 | 2015 |
| S4-5: Comparison of PAM50 Risk of Recurrence (ROR) Score with OncotypeDx and IHC4 for Predicting Residual Risk of RFS and Distant-(D) RFS after Endocrine Therapy: A TransATAC … M Dowsett, E Lopez-Knowles, K Sidhu, S Pineda, JW Cowens, S Ferree, ... Cancer Research 71 (24_Supplement), S4-5-S4-5, 2011 | 21 | 2011 |
| Peripheral blood RNA sequencing unravels a differential signature of coding and noncoding genes by types of kidney allograft rejection S Pineda, S Sur, T Sigdel, M Nguyen, E Crespo, A Torija, M Meneghini, ... Kidney international reports 5 (10), 1706-1721, 2020 | 15 | 2020 |
| TransATAC investigators: Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole … K Lundgren, M Brown, S Pineda, J Cuzick, J Salter, L Zabaglo, A Howell, ... Breast Cancer Res 14 (2), R57, 2012 | 14 | 2012 |
| A pan-cancer analysis of tumor-infiltrating B cell repertoires K Yu, A Ravoor, N Malats, S Pineda, M Sirota Frontiers in immunology 12, 790119, 2022 | 11 | 2022 |
| Tumor-infiltrating B-and T-cell repertoire in pancreatic cancer associated with host and tumor features S Pineda, E Lopez de Maturana, K Yu, A Ravoor, I Wood, N Malats, ... Frontiers in immunology 12, 730746, 2021 | 10 | 2021 |
| Prognostic value of a combined estrogen receptor, progesterone receptor J Cuzick, M Dowsett, S Pineda, C Wale, J Salter, E Quinn Ki-67, and human epidermal growth factor receptor 2, 2011 | 7 | 2011 |
